Are you Dr. Rosenthal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
111 New Hampshire Ave
Ste 3
Portsmouth, NH 03801Phone+1 603-988-0951Fax+1 603-441-3722
Summary
- Dr. Ian Rosenthal, MD is a board certified pathologist in Portsmouth, New Hampshire. He is currently licensed to practice medicine in New Hampshire, Indiana, and Maine.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Dermatopathology, 2015 - 2016
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2012 - 2015
- Johns Hopkins University School of MedicineClass of 2012
Certifications & Licensure
- OH State Medical License 2016 - 2026
- ME State Medical License 2023 - 2026
- IN State Medical License 2023 - 2025
- NH State Medical License 2023 - 2025
- FL State Medical License 2018 - 2024
- UT State Medical License 2022 - 2024
- KY State Medical License 2016 - 2024
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 151 citationsBactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of TuberculosisSandeep Tyagi, Eric L. Nuermberger, Tetsuyuki Yoshimatsu, Kathy N. Williams, Ian M. Rosenthal
Antimicrobial Agents and Chemotherapy. 2005-06-01 - 68 citationsPotent Twice-Weekly Rifapentine-containing Regimens in Murine TuberculosisIan M. Rosenthal, Kathy N. Williams, Sandeep Tyagi, Charles A. Peloquin, Andrew Vernon
American Journal of Respiratory and Critical Care Medicine. 2006-07-01 - 82 citationsParadoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of TuberculosisDeepak V. Almeida, Eric L. Nuermberger, Rokeya Tasneen, Ian M. Rosenthal, Sandeep Tyagi
Antimicrobial Agents and Chemotherapy. 2009-10-01
Grant Support
- Improved TB Drug Delivery With Novel Polymeric CarriersNational Institute Of Biomedical Imaging And Bioengineering2005–2006